Calls Now Open
2022 ADDF-Harrington and 2023 Harrington UK Rare Disease Programs
Medicines in the making
Institutions supported
Companies launched
Medicines in the clinic
Licenses to pharma
In addition to receiving funding, every scholar is paired with a results-oriented and mission-focused team from our Therapeutics Development Center. Teams consist of a project manager and experienced pharma and business development advisors with a track record of bringing new drugs to market.
Learn MoreOur pipeline represents the best science coming out of academic laboratories. Projects are selected for their innovation and potential for clinical impact. Our team proactively moves them forward to commercial viability and clinical use.
See all discoveries
Focus on epigenetics, neurovascular health, and other novel approaches
Continue Reading
Grant programme seeks to advance novel therapies for rare diseases
Continue Reading
Focus on epigenetics, neurovascular health, and other novel approaches
Continue Reading
More than 150 drug discovery projects now supported by Harrington Discovery Institute
Continue Reading